Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis

<div>Forest plot of the odds of VTE in ovarian cancer patients that have ascites at diagnosis (versus nonsignificant ascites). This figure shows the pooled odd of ascites at diagnosis (versus nonsignificant ascites). The total pooled odds are 2.12 (1.51-2.96).</div>

Obstetrics and Gynecology International

fig6

Figure 6

Figure 6: Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis 